← Leaderboards
Saurabh Aggarwal
University Of Alabama At Birmingham
$3,145,942
Attributed
$3,145,942
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $816.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,145,942 · 2
By mechanism
R01$1,843,138 · 1
U01$1,302,804 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Sadis Matalon$21,362,558
- Mitchell Alan Olman$8,130,633
- Deodutta Roy$2,087,628
- Kai Jiao$7,147,323
- Kristopher R. Genschmer$1,930,500
Others in their field
Other Emerging Leaders on “Peripheral”
- Thomas Denny · Duke University$29,111,395
- James Dale Berry · Brigham And Women'S Hospital$19,493,214
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Niels Kuster · It'Is Foundation$18,600,051
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$14,520,572
- Peter John Hunter · University Of Auckland$11,770,750
Research focus
PeripheralInnovationInflammatoryNeutrophilPlasmaLeukocytesHemeImpairmentLymphocyteMediatingPreventProteinsBindingMacrophageCellsAttenuatedHemolysisHiv-1Antiretroviral TherapyAntioxidantsAcquired Immunodeficiency SyndromeChronic DiseaseAddictionChronic Pain
Grant awards (9)
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics$360,638
R01 · FY2025 · DA · contact PI
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics$368,750
R01 · FY2024 · DA · contact PI
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics$371,250
R01 · FY2023 · DA · contact PI
Identification of AMD3100 (Plerixafor) as a lead compound for chlorine toxicity$255,439
U01 · FY2023 · ES · contact PI
Identification of AMD3100 (Plerixafor) as a potential lead compound for chlorine toxicity$166,914
U01 · FY2023 · ES · contact PI
Identification of AMD3100 (Plerixafor) as a potential lead compound for chlorine toxicity$434,951
U01 · FY2022 · ES · contact PI
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics$371,250
R01 · FY2022 · DA · contact PI
Identification of AMD3100 (Plerixafor) as a potential lead compound for chlorine toxicity$445,500
U01 · FY2021 · ES · contact PI
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics$371,250
R01 · FY2021 · DA · contact PI